Back Back
RCB0999 : MKN7  update : 2018/07/06
Commentc-erbB-2 expressing gastric adenocarcinoma. Differentiated type.
Comment from the depositor
Terms and conditionsBasically, there is no restriction regarding academic use.
Order Form Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, Category I and II, depending on the sort of user institutions and the purposes of use.Please use an appropriate MTA(to see).In case of Restriction "a" or "f", please contact RIKEN BRC( regarding any kind of for-profit use.
Basic information Depositor Motoyama, Teiichi
Originator Hojo, Haruto
Year of deposit 1994
Animal human < Mammals
Genus Homo
Species sapiens
Race Japanese
Gender Male
Age at sampling 39 years
Tissue stomach, lymph node meta
Metastastatic ability Yes
Metastatsd tissue lymph node
Genetics Gastric adenocarcinoma
Classification cancer
Year of origin 1975
History Hojo, Haruto - Motoyama, Teiichi
Lifespan infinite
Morphology epithelial-like
deposit info
lot info
Medium Medium List
Culture type Adherent cells
Medium and additives RPMI1640 + 10% FBS
Antibiotics Free
Passage method 0.25% trypsin
Culture information Passage ratio 1 : 8 split
SC frequency Subculture : once/week, Medium Renewal : 2 times/week
Temperature 37 ℃
CO2 concentration 5 %
Freeze medium Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma (-)
STR (human) OK
Virus (HIV) (-)
Isozyme LD, NP
Chromosome mode 51-71(50) : /64(1),65(3),66(4),67(6),68(7),69(14)/
deposit info
lot info
Reference information Reference 6
User's Publication 64

To topTop
1889  Comparison of seven cell lines derived from human gastric carcinomas.  Motoyama T, Hojo H, Watanabe H  Acta Pathol Jpn  1986  36:65-83  PubMed ID: 3962675
5050  Alloimmunization with cultured human stomach cancer cell lines and the establishment of human-human hybridomas producing monoclonal antibodies.  Koyama K, Akiyama K, Kawahara H, Egashira A, Murakami H.  Jpn J Cancer Res  1990  81(10):967-70  PubMed ID: 2121682
5075  Detection of amplified DNA sequences in gastric cancers by a DNA renaturation method in gel.  Nakatani H, Tahara E, Yoshida T, Sakamoto H, Suzuki T, Watanabe H, Sekiguchi M, Kaneko Y, Sakurai M, Terada M, et al.  Jpn J Cancer Res  1986  77(9):849-53  PubMed ID: 3095279
4501  Demethylation of the synuclein gamma gene CpG island in primary gastric cancers and gastric cancer cell lines.  Yanagawa N, Tamura G, Honda T, Endoh M, Nishizuka S, Motoyama T.  Clin Cancer Res  2004  10(7):2447-51  PubMed ID: 15073123
1861  Carcinoembryonic antigen production in human gastric cancer cell lines in vitro and in nude mice.  Motoyama T, Watanabe H.  Gan  1983  74(5):679-86  PubMed ID: 6642141
4399  Spreading of methylation within RUNX3 CpG island in gastric cancer.  Homma N, Tamura G, Honda T, Matsumoto Y, Nishizuka S, Kawata S, Motoyama T.  Cancer Sci  2006  97(1):51-6  PubMed ID: 16367921

To topTop
User's Publication
3332  Caspase-8 is scarcely silenced and its activity is well correlated with the anticancer effect of tumor necrosis factor-related apoptosis-inducing ligand in gastric cancer cells.  Kanehara, Isao, Nakata, Bunzo, Hirakawa, Kosei  Oncol Rep  2005  14:1249-53  PubMed ID: 16211292
2194  Analysis of the DPC4 gene in gastric carcinoma  Nishizuka S, Tamura G, Maesawa C, Sakata K, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R  Jpn J Cancer Res  1997  88:335-339  PubMed ID: 9197522
3103  Anti-Fas antibody-induced apoptosis and its signal transduction in human gastric carcinoma cell lines.  Adachi, Keiko, Osaki, Mitsuhiko, Kase, Satoru, Takeda, Ami, Ito, Hisao  Int J Oncol  2003  23:713-9  PubMed ID: 12888908
2921  Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis.  Ishihara, Shunji, Rumi, Mohammad Azharul Karim, Kadowaki, Yasunori, Ortega-Cava, Cesar Francisco, Yuki, Takafumi, Yoshino, Nagisa, Miyaoka, Youichi, Kazumori, Hideaki, Ishimura, Norihisa, Amano, Yuji, Kinoshita, Yoshikazu  J Immunol  2004  173:1406-16  PubMed ID: 15240737
3105  Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma.  Osaki M, Moriyama M, Adachi K, Nakada C, Takeda A, Inoue Y, Adachi H, Sato K, Oshimura M, Ito H  Eur J Clin Invest  2004  34:605-12  PubMed ID: 15379759
3109  COX-2 inhibitor, NS398, enhances Fas-mediated apoptosis via modulation of the PTEN-Akt pathway in human gastric carcinoma cell lines.  Honjo, Soichiro, Osaki, Mitsuhiko, Ardyanto, Tonang Dwi, Hiramatsu, Toshiki, Maeta, Noritaka, Ito, Hisao  DNA Cell Biol  2005  24:141-7  PubMed ID: 15767780
7159  Divergence between the Highly Virulent Zoonotic Pathogen Helicobacter heilmannii and Its Closest Relative, the Low-Virulence "Helicobacter ailurogastricus" sp. nov.  Joosten M, Linden S, Rossi M, Tay AC, Skoog E, Padra M, Peters F, Perkins T, Vandamme P, Van Nieuwerburgh F, D'Herde K, Van den Broeck W, Flahou B, Deforce D, Ducatelle R, Marshall B, Haesebrouck F, Smet A.  Infect. Immun.  2015  84:293-306  PubMed ID: 26527212
7313  New NCI-N87-derived human gastric epithelial line after human telomerase catalytic subunit over-expression.  Saraiva-Pava K, Navabi N, Skoog EC, Linden SK, Oleastro M, Roxo-Rosa M.  World J. Gastroenterol.  2015  21:6526-42  PubMed ID: 26074691
7470  The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer.  Sakimura S, Sugimachi K, Kurashige J, Ueda M, Hirata H, Nambara S, Komatsu H, Saito T, Takano Y, Uchi R, Sakimura E, Shinden Y, Iguchi T, Eguchi H, Oba Y, Hoka S, Mimori K.  Ann. Surg. Oncol.  2015  22 Suppl 3:S1436-43  PubMed ID: 25707493
7876  Aberrant gene methylation is a biomarker for the detection of cancer cells in peritoneal wash samples from advanced gastric cancer patients.  Hiraki M, Kitajima Y, Koga Y, Tanaka T, Nakamura J, Hashiguchi K, Noshiro H, Miyazaki K.  Ann. Surg. Oncol.  2011  18:3013-9  PubMed ID: 21409489
7990  Expression of BMP-7 in human gastric cancer and its clinical significance.  Aoki M, Ishigami S, Uenosono Y, Arigami T, Uchikado Y, Kita Y, Kurahara H, Matsumoto M, Ueno S, Natsugoe S.  Br. J. Cancer  2011  104:714-8  PubMed ID: 21224856
8253  Reduced expression of RAS protein activator like-1 in gastric cancer.  Seto M, Ohta M, Ikenoue T, Sugimoto T, Asaoka Y, Tada M, Mohri D, Kudo Y, Ijichi H, Tateishi K, Otsuka M, Hirata Y, Maeda S, Koike K, Omata M.  Int. J. Cancer  2010  128:1293-302  PubMed ID: 20473946
3375  p53-Independent negative regulation of p21/cyclin-dependent kinase-interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cells.  Ohta M, Tateishi K, Kanai F, Watabe H, Kondo S, Guleng B, Tanaka Y, Asaoka Y, Jazag A, Imamura J, Ijichi H, Ikenoue T, Sata M, Miyagishi M, Taira K, Tada M, Kawabe T, Omata M.  Cancer Res.  2005  65:10822-9  PubMed ID: 16322228
9606  The Helicobacter heilmannii hofE and hofF Genes are Essential for Colonization of the Gastric Mucosa and Play a Role in IL-1β-Induced Gastric MUC13 Expression.  Cheng L, Mirko R, Sara L, Medea P, Caroline B, Eva B, Myrthe J, Bram F, Wim VD, Richard D, Freddy H, Annemieke S.  Helicobacter  2016  21:504-522  PubMed ID: 26935145
9610  Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus.  Saju P, Murata-Kamiya N, Hayashi T, Senda Y, Nagase L, Noda S, Matsusaka K, Funata S, Kunita A, Urabe M, Seto Y, Fukayama M, Kaneda A, Hatakeyama M.  Nat Microbiol  2016  1:16026  PubMed ID: 27572445
9788  PTEN loss is associated with a poor response to trastuzumab in HER2-overexpressing gastroesophageal adenocarcinoma.  Deguchi Y, Okabe H, Oshima N, Hisamori S, Minamiguchi S, Muto M, Sakai Y.  Gastric Cancer  2017  20:416-427  PubMed ID: 27517839
9928  Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer.  Diaz-Lagares A, Crujeiras AB, Lopez-Serra P, Soler M, Setien F, Goyal A, Sandoval J, Hashimoto Y, Martinez-Cardús A, Gomez A, Heyn H, Moutinho C, Espada J, Vidal A, Paúles M, Galán M, Sala N, Akiyama Y, Martínez-Iniesta M, Farré L, Villanueva A, Gross M, Diederichs S, Guil S, Esteller M.  Proc. Natl. Acad. Sci. U.S.A.  2016  113:E7535-E7544  PubMed ID: 27821766
9945  Gene amplification of CCNE1, CCND1, and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.  Ooi A, Oyama T, Nakamura R, Tajiri R, Ikeda H, Fushida S, Dobashi Y.  Hum. Pathol.  2017  61:58-67  PubMed ID: 27864121
9978  Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.  Kneissl J, Hartmann A, Pfarr N, Erlmeier F, Lorber T, Keller S, Zwingenberger G, Weichert W, Luber B.  J. Cancer Res. Clin. Oncol.  2017  143:573-600  PubMed ID: 27933395
10134  Sodium Channel Subunit SCNN1B Suppresses Gastric Cancer Growth and Metastasis via GRP78 Degradation.  Qian Y, Wong CC, Xu J, Chen H, Zhang Y, Kang W, Wang H, Zhang L, Li W, Chu ESH, Go MYY, Chiu PWY, Ng EKW, Chan FKL, Sung JJY, Si J, Yu J.  Cancer Res.  2017  77:1968-1982  PubMed ID: 28202509
10258  ASPP2 suppresses invasion and TGF-β1-induced epithelial-mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer.  Gen Y, Yasui K, Kitaichi T, Iwai N, Terasaki K, Dohi O, Hashimoto H, Fukui H, Inada Y, Fukui A, Jo M, Moriguchi M, Nishikawa T, Umemura A, Yamaguchi K, Konishi H, Naito Y, Itoh Y.  Cancer Lett.  2017  398:52-61  PubMed ID: 28400336
10437  Heat shock-induced HIKESHI protects cell viability via nuclear translocation of heat shock protein 70.  Yanoma T, Ogata K, Yokobori T, Ide M, Mochiki E, Toyomasu Y, Yanai M, Kogure N, Kimura A, Suzuki M, Nakazawa N, Bai T, Oyama T, Asao T, Shirabe K, Kuwano H.  Oncol. Rep.  2017  38:1500-1506  PubMed ID: 28731175
10460  Locoregional therapy with α-emitting trastuzumab against peritoneal metastasis of human epidermal growth factor receptor 2-positive gastric cancer in mice.  Li HK, Morokoshi Y, Nagatsu K, Kamada T, Hasegawa S.  Cancer Sci.  2017  108:1648-1656  PubMed ID: 28514062
10586  The H19-PEG10/IGF2BP3 axis promotes gastric cancer progression in patients with high lymph node ratios.  Ishii S, Yamashita K, Harada H, Ushiku H, Tanaka T, Nishizawa N, Yokoi K, Washio M, Ema A, Mieno H, Moriya H, Hosoda K, Waraya M, Katoh H, Watanabe M.  Oncotarget  2017  8:74567-74581  PubMed ID: 29088808
10787  Identification of selective inhibitors for diffuse-type gastric cancer cells by screening of annotated compounds in preclinical models.  Shimada S, Akiyama Y, Mogushi K, Ishigami-Yuasa M, Kagechika H, Nagasaki H, Fukamachi H, Yuasa Y, Tanaka S.  Br. J. Cancer  2018  118:972-984  PubMed ID: 29527007
11145  CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1α axis to inhibit gastric tumorigenesis.  Li W, Wong CC, Zhang X, Kang W, Nakatsu G, Zhao Q, Chen H, Go MYY, Chiu PWY, Wang X, Ji J, Li X, Cai Z, Ng EKW, Yu J.  Oncogene  2018  37(50):6383-6398  PubMed ID: 30054562
11095  Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer.  Kim M, Pyo S, Kang CH, Lee CO, Lee HK, Choi SU, Park CH.  PLoS ONE  2018  13(6):e0198347  PubMed ID: 29874279
11231  Up-regulation and tumor-promoting role of SPHK1 were attenuated by miR-330-3p in gastric cancer.  Wang Z, Qu H, Gong W, Liu A.  IUBMB Life  2018    PubMed ID: 30281914
4300  Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines.  Keller S, Zwingenberger G, Ebert K, Hasenauer J, Wasmuth J, Maier D, Haffner I, Schierle K, Weirich G, Luber B.  Mol Oncol  2018    PubMed ID: 29325228
4313  Overexpression of YEATS4 contributes to malignant outcomes in gastric carcinoma.  Kiuchi J, Komatsu S, Imamura T, Nishibeppu K, Shoda K, Arita T, Kosuga T, Konishi H, Shiozaki A, Kubota T, Okamoto K, Fujiwara H, Ichikawa D, Tsuda H, Otsuji E.  Am J Cancer Res  2018    PubMed ID: 30662802
4380  Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer.  Yoshioka T, Shien K, Namba K, Torigoe H, Sato H, Tomida S, Yamamoto H, Asano H, Soh J, Tsukuda K, Nagasaka T, Fujiwara T, Toyooka S.  Cancer Sci.  2018  109(4):1166-1176  PubMed ID: 29465762
3733  Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer.  Nishikawaji T, Akiyama Y, Shimada S, Kojima K, Kawano T, Eishi Y, Yuasa Y, Tanaka S.  Oncotarget  2016  7(41):67251-67265  PubMed ID: 27572307
3796  Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines.  Fukami T, Fukuhara H, Kuramochi M, Maruyama T, Isogai K, Sakamoto M, Takamoto S, Murakami Y.  Int J Cancer  2003  107(1):53-9  PubMed ID: 12925956
5806  Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism.  Shiroki T et al  Cancer Sci  2017  108(5):931-940  PubMed ID: 28235245
5817  Expression of Fibroblast Growth Factor 10 Is Correlated with Poor Prognosis in Gastric Adenocarcinoma.  Sun Q, Lin P, Zhang J, Li X, Yang L, Huang J, Zhou Z, Liu P, Liu N.  Tohoku J Exp Med  2015  236(4):311-8  PubMed ID: 26268776
5819  CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer.  Yoshida K, Tsujimoto H, Matsumura K, Kinoshita M, Takahata R, Matsumoto Y, Hiraki S, Ono S, Seki S, Yamamoto J, Hase K.  Cancer Med  2015  4(9):1322-33  PubMed ID: 26077800
5827  ERC/mesothelin is expressed in human gastric cancer tissues and cell lines.  Ito T, Kajino K, Abe M, Sato K, Maekawa H, Sakurada M, Orita H, Wada R, Kajiyama Y, Hino O.  Oncol Rep  2014  31(1):27-33  PubMed ID: 24146039
5840  Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2.  Kawada M, Inoue H, Ohba S, Hatano M, Amemiya M, Hayashi C, Usami I, Abe H, Watanabe T, Kinoshita N, Igarashi M, Masuda T, Ikeda D, Nomoto   J Antibiot (Tokyo)  2013  66(9):543-8  PubMed ID: 23632919
5848  Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks.  Kataoka Y, Mukohara T, Tomioka H, Funakoshi Y, Kiyota N, Fujiwara Y, Yashiro M, Hirakawa K, Hirai M, Minami H.  Invest New Drugs  2012  30(4):1352-60  PubMed ID: 21655918
5852  Inhibition of the mTOR/S6K signal is necessary to enhance fluorouracil-induced apoptosis in gastric cancer cells with HER2 amplification.  Tomioka H, Mukohara T, Kataoka Y, Ekyalongo RC, Funakoshi Y, Imai Y, Kiyota N, Fujiwara Y, Minami H.  Int J Oncol  2012  41(2):551-8  PubMed ID: 22614071
5855  Discovery of SLC3A2 cell membrane protein as a potential gastric cancer biomarker: implications in molecular imaging.  Yang Y, Toy W, Choong LY, Hou P, Ashktorab H, Smoot DT, Yeoh KG, Lim YP.  J Proteome Res  2012  11(12):5736-47  PubMed ID: 23116296
5865  Anti-tumor activity of the proteasome inhibitor bortezomib in gastric cancer.  Nakata W, Hayakawa Y, Nakagawa H, Sakamoto K, Kinoshita H, Takahashi R, Hirata Y, Maeda S, Koike K.  Int J Oncol  2011  39(6):1529-36  PubMed ID: 21785822
5866  Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer.  Nakamura J, Kitajima Y, Kai K, Hashiguchi K, Hiraki M, Noshiro H, Miyazaki K.  Am J Pathol  2011  178(2):515-24  PubMed ID: 21281785
5869  Efficient gene transduction in HER2-expressing cancer cells by two recombinant adenovirus vectors with HER2 promoter and Cre/loxP system  Tatsuya Nodagashira,Hiroki Odagiri,Shojiro-Kazunori Ikenaga,Masaki Maruyama, Toshiyuki Sato and Kenichi Hakamada  Hirosaki Med J  2010  61:26―34 
5884  MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy.  Lindén SK, Sheng YH, Every AL, Miles KM, Skoog EC, Florin TH, Sutton P, McGuckin MA.  PLoS Pathog  2009  5(10):e1000617  PubMed ID: 19816567
5918  Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer.  Ono HA, Davydova JG, Adachi Y, Takayama K, Barker SD, Reynolds PN, Krasnykh VN, Kunisaki C, Shimada H, Curiel DT, Yamamoto M.  J Gastroenterol  2005  40(1):31-42  PubMed ID: 15692787
5922  Prognostic significance and different properties of survivin splicing variants in gastric cancer.  Meng H, Lu C, Mabuchi H, Tanigawa N.  Cancer Lett  2004  216(2):147-55  PubMed ID: 15533590
5923  Enhanced photodynamic antitumor effect on gastric cancer by a novel photosensitive stealth liposome.  Namiki Y, Namiki T, Date M, Yanagihara K, Yashiro M, Takahashi H.  Pharmacol Res.   2004  50(1):65-76  PubMed ID: 15082031
5928  Cyclin A correlates with the sensitivity of human cancer cells to cytotoxic effects of 5-FU.  Kawashima R, Haisa M, Kimura M, Takaoka M, Shirakawa Y, Takeda H, Uetsuka H, Gunduz M, Nagai N, Tanaka N, Naomoto Y.  Int J Oncolo  2004  24(2):273-8  PubMed ID: 14719102
5936  Intermittent FLDP: 24-h infusion of 5-FU on days 1, 3 and 5 combined with low-dose cisplatin on days 1-5 for gastric cancer, and its pharmacologic and kinetic rationale.  Terashima M, Irinoda T, Kawamura H, Takagane A, Abe K, Oyama K, Fujiwara H, Saito K, Gotoh M, Shirasaka T.  Cancer Chemother Pharmacol  2003  51(3):240-6  PubMed ID: 12655443
5939  Activation of prostaglandin E2-receptor EP2 and EP4 pathways induces growth inhibition in human gastric carcinoma cell lines.  Okuyama T, Ishihara S, Sato H, Rumi MA, Kawashima K, Miyaoka Y, Suetsugu H, Kazumori H, Cava CF, Kadowaki Y, Fukuda R, Kinoshita Y.  J Lab Clin Med  2002  140(2):92-102  PubMed ID: 12228765
5940  Interleukin-1beta expression in human gastric carcinoma with Epstein-Barr virus infection.  Chong JM, Sakuma K, Sudo M, Osawa T, Ohara E, Uozaki H, Shibahara J, Kuroiwa K, Tominaga S, Hippo Y, Aburatani H, Funata N, Fukayama M.  J Virol  2002  76(13):6825-31  PubMed ID: 12050395
5946  Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites.  Sakakura C, Hagiwara A, Nakanishi M, Shimomura K, Takagi T, Yasuoka R, Fujita Y, Abe T, Ichikawa Y, Takahashi S, Ishikawa T, Nishizuka I, Morita T, Shimada H, Okazaki Y, Hayashizaki Y, Yamagishi H.  Br J Cancer  2002  87(10):1153-61  PubMed ID: 12402156
5950  Mass spectrometric high-throughput analysis of serum-free conditioned medium from cancer cell lines.  Sato K, Sasaki K, Akiyama Y, Yamaguchi K.  Cancer Lett  2001  170(2):153-9  PubMed ID: 11463493
5953  Simple quantitative assay of alpha-fetoprotein mRNA in liver tissue using the real-time detection polymerase chain reaction assay - its application for clinical use.  Matsumura M, Ijichi M, Shiratori Y, Togo G, Hikiba Y, Inoued K, Kohara M, Omata M.  Hepatol Res  2001  20(1):84-96  PubMed ID: 11282488
5958  Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation.  Sakakura C, Hagiwara A, Yasuoka R, Fujita Y, Nakanishi M, Masuda K, Shimomura K, Nakamura Y, Inazawa J, Abe T, Yamagishi H.  Br J Cancer  2001  84(6):824-31  PubMed ID: 11259099
5966  Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists.  Sato H, Ishihara S, Kawashima K, Moriyama N, Suetsugu H, Kazumori H, Okuyama T, Rumi MA, Fukuda R, Nagasue N, Kinoshita Y.  Br J Cancer  2000  83(10):1394-400  PubMed ID: 11044367
5973  Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.  Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R.  Genes Chromosomes Cancer  1997  20(1):98-102  PubMed ID: 9290961
6115  Expression patterns of the tumor suppressor PDCD4 and correlation with β-catenin expression in gastric cancers.  Kakimoto T, Shiraishi R, Iwakiri R, Fujimoto K, Takahashi H, Hamajima H, Mizuta T, Ideguchi H, Toda S, Kitajima Y, Ozaki I, Matsuhashi S.  Oncol Rep  2011  26(6):1385-92  PubMed ID: 21894439
6139  IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells.  Jin SH, Akiyama Y, Fukamachi H, Yanagihara K, Akashi T, Yuasa Y.  Int J Cancer  2008  122(5):1040-6  PubMed ID: 17957782
6160  Abnormal expression and function of the E-cadherin-catenin complex in gastric carcinoma cell lines.  Jawhari AU, Noda M, Farthing MJ, Pignatelli M.  Br J Cancer  1999  80(3-4):322-30  PubMed ID: 10408833
11505  Tandem repeats of the 5' flanking region of human MUC5AC have a role as a novel enhancer in MUC5AC gene expression.  Kageyama-Yahara N, Yamamichi N, Takahashi Y, Takeuchi C, Matsumoto Y, Sakaguchi Y, Koike K.  Biochem Biophys Rep  2019  18:100632  PubMed ID: 30993217
11568  Characterization of the non-glandular gastric region microbiota in Helicobacter suis-infected versus non-infected pigs identifies a potential role for Fusobacterium gastrosuis in gastric ulceration.  De Witte C, Demeyere K, De Bruyckere S, Taminiau B, Daube G, Ducatelle R, Meyer E, Haesebrouck F.  Vet. Res.  2019  50(1):39  PubMed ID: 31126330
6410  Is parainfluenza virus a threatening virus for human cancer cell lines?  Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.  Hum Cell  2009  22(3):81-4  PubMed ID: 19624309

Back Back Return Top Page